FDA Enforcement Class II Terminated

Randox Liquid Cardiac Controls Catalogue Number CQ5051

Recall: Z-0412-2020 · Reported November 27, 2019

Enforcement

Recall Number
Z-0412-2020
Event ID
84044
Classification
Class II
Status
Terminated
Product Type
Devices
Firm
Randox Laboratories, Limited
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
E-Mail
Report Date
November 27, 2019
Initiation Date
October 4, 2019
Classification Date
November 15, 2019
Termination Date
July 6, 2020
Address
Ardmore; 55 The Diamond Road, N/A, Crumlin, N/A, N/A, United Kingdom

Description

Randox Liquid Cardiac Controls Catalogue Number CQ5051

Reason

Removal of claims for N-proBNP in the Liquid Cardiac Control model numbers CQ5051 due to an observed decrease in recovery for N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) in recent lots.

Code Info

Catalogue Number: CQ5051 GTIN: 05055273207446 Batch/lot: 4243CK (Exp. 28Nov2019), 4246CK (Exp. 28Nov2019), 4249CK (Exp. 28Nov2019), 4260CK (Exp. 28Nov2019), 4311CK (Exp. 28May2020), 4317CK (Exp. 28May2020)

Distribution

US Distribution: WV, CA, DE, NJ, NY, GA, IN, PR OUS Distribution: CA, PL, CH, JP, NL, IT, CN, GB, IE, RU, MD, BY, SA, VN, AE, BH, DK, CO, ES, FR, TW, PH, TH, OM, HU, IN, KR, ZA, AU, CZ, PE, CL, IR, NZ, BE, DE, BA, SV, SK, HK, PT, PK, BR, TR, UA, SE, QA, LT, PE,

Quantity

6,208